ENTREP1 and lung cancer: Integrating single−cell and bulk transcriptomes links malignant epithelial state programs to prognosis, yields a practical eight−gene risk model validated in multiple LUAD cohorts, and nominates FAM189A2 as a putative tumor suppressor and potential biomarker in lung cancer.